Pharmacy Times
DECEMBER 23, 2024
The approval of the generic to liraglutide injection, currently in shortage, could help increase patient access to the type 2 diabetes treatment.
Drug Topics
DECEMBER 23, 2024
Check out this list of our top 5 most read Drug Topics stories from the year 2024.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
DECEMBER 23, 2024
The company already moved to cut its entire commercial sales force following several FDA setbacks in its efforts to introduce sotagliflozin in diabetes.
Drug Topics
DECEMBER 23, 2024
Researchers reviewed Medicaid policies to understand vaccine coverage and reimbursement rates among physicians and pharmacists.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
DECEMBER 23, 2024
Pharmacists are essential in preventing the significant health and economic burden of respiratory syncytial virus (RSV) infections in older adults through vaccination.
Drug Topics
DECEMBER 23, 2024
Provisions under the Inflation Reduction Act have ensured cost savings for patients prescribed drugs covered under Medicare Part B.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Topics
DECEMBER 23, 2024
A study found that patients with medication-overuse headache and neck pain experience earlier onset of primary headache and decreased quality of life.
Compounding Pharmacy of America
DECEMBER 23, 2024
Learn how compounding pharmacies ensure safety and reliability through rigorous standards, sterile preparations, and personalized solutions for unique healthcare needs. The post Are Compounding Pharmacies Safe? Everything You Need to Know appeared first on Compounding Pharmacy of America.
Drug Topics
DECEMBER 23, 2024
Senators Elizabeth Warren and Tina Smith have reintroduced the Pharmaceutical Supply Chain Defense and Enhancement Act originally established in 2020.
Pharmaceutical Technology
DECEMBER 23, 2024
Lillys Zepbound has become the first prescription medicine approved to treat adults with moderate to severe obstructive sleep apnoea (OSA) and obesity.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
DECEMBER 23, 2024
A conversation with Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, professor of pharmacy practice at Massachusetts College of Pharmacy and Health Sciences.
The Checkup by Singlecare
DECEMBER 23, 2024
In a world where the battle against obesity and diabetes is more pressing than ever, a groundbreaking medication is making waves for its dual capabilities. Ozempic (active ingredient semaglutide), a prescription medication manufactured by Novo Nordisk, is approved by the U.S. Food and Drug Administration (FDA) to help control blood sugar in patients with Type 2 diabetes.
Drug Topics
DECEMBER 23, 2024
Researchers explored the impacts of natural bioactive compounds for the treatment of acute pancreatitis.
Pharmacy Times
DECEMBER 23, 2024
Currently available for prescription in the United States, vibegron is now the first and only 3 agonist FDA approved to treat patients living with OAB and being treated for BPH.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmaceutical Technology
DECEMBER 23, 2024
Pfizer has gained accelerated approval from the US FDA for BRAFTOVI in conjunction with cetuximab and mFOLFOX6 for treating mCRC.
Pharmacy Times
DECEMBER 23, 2024
Pharmacy Times attended the 2024 San Antonio Breast Cancer Symposium from December 10 to December 13.
Pharmaceutical Technology
DECEMBER 23, 2024
GlobalData analysis sees Lilly's investment in UK life sciences as an opportunity to drive economic growth whilst improving public health.
Pharmacy Times
DECEMBER 23, 2024
Short-term spinal cord stimulation could provide long-term pain relief and improve the overall quality of life for individuals with herpes zoster-associated pain and postherpetic neuralgia.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmaceutical Technology
DECEMBER 23, 2024
Vertex has won two cystic fibrosis approvals from the FDA, but the agency included high-level safety warnings.
Pharmacy Times
DECEMBER 23, 2024
A panelist discusses how differences in HER2-positive, HER2-low, and HER2-negative status impact clinical decision-making.
Pharmaceutical Technology
DECEMBER 23, 2024
Though still below boom levels seen a few years ago, 2024 compares favourably to 2023, and signs suggest that growth will continue into 2025.
Pharmacy Times
DECEMBER 23, 2024
Concizumab-mtci is a subcutaneous, monoclonal antibody designed to achieve hemostasis in all hemophilia types.
Pharmaceutical Technology
DECEMBER 23, 2024
SK bioscience and Sanofi have expanded their agreement to jointly develop pneumococcal conjugate vaccines (PCVs).
Pharmacy Times
DECEMBER 23, 2024
Pharmacists can optimize IVIG treatment for BK nephropathy in kidney transplant recipients by educating providers and monitoring for infusion reactions.
Fierce Pharma
DECEMBER 23, 2024
The FDA approved Novo Nordisk's tissue factor pathway inhibitor (TFPI) antagonist concizumab as a once-a-day treatment to prevent or curb the frequency of bleeding episodes in patients ages 12 and older who have hemophilia A or B with inhibitors. The green light follows a rejection in 2023 and a trial pause over safety concerns several years before that.
Pharmacy Times
DECEMBER 23, 2024
The 2025 GOLD Report emphasizes the importance of tailoring combination treatments based on patient factors like eosinophil counts and exacerbation history.
STAT
DECEMBER 23, 2024
For patients who receive gender-affirming surgery, the experience can feel like a rebirth. “I decided that the old me would die on the table and then the new me would come up from it,” said Wendy Grogan, 48, a trans woman who recently pursued vocal and facial procedures, top surgery, and a vaginoplasty — the creation of a vagina from a penis, scrotum, and other tissue.
Pharmacy Times
DECEMBER 23, 2024
By aligning the pharmacy revenue cycle with the 340B Drug Pricing Program, organizations can maximize revenue capture from medications while ensuring compliance with 340B requirements, leading to enhanced financial performance and improved care for underserved populations.
European Pharmaceutical Review
DECEMBER 23, 2024
Researchers in Australia have created an innovative drug delivery system that utilises a metalbiomolecule network (MBN) comprising of non-toxic metal ions together with phosphonate biomolecules, eg, DNA. As the MBN nanoparticles do not require complicated drug carriers and the materials are bio-compatible, the system has potential to boost successful drug development, according to first author Dr Wanjun Xu.
Pharmacy Times
DECEMBER 23, 2024
Pharmacists can help address nicotine addiction by recommending FDA-approved smoking cessation methods and educating on the risks associated with electronic cigarette use.
pharmaphorum
DECEMBER 23, 2024
Stay updated on the latest Good Manufacturing Practices (GMP) and quality compliance standards in the digital era with our comprehensive guide. Learn how to ensure your products meet regulatory requirements.
Pharmacy Times
DECEMBER 23, 2024
The nasal spray label resembles that of the FDA-approved epinephrine injection, leading to potential dosing errors.
Fierce Healthcare
DECEMBER 23, 2024
AI and software company Commure has acquired Memora Health, a digital care navigation platform launched out of the Harvard Innovation Labs. | Health tech company Commure has acquired Memora Health, a Harvard Innovation Labs company backed by General Catalyst.
Expert insights. Personalized for you.
123 
Let's personalize your content